CHICAGO, IL / ACCESS Newswire / January 22, 2025 / ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, ...

The rising incidence of prostate cancer in Nigeria, as highlighted in a recent report, underscores a critical public health challenge.

Exelixis, Inc. (NASDAQ:EXEL), currently trading near $33, continues to build on the success of its flagship product ...

CHICAGO - Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group with a current market capitalization of $19.54 million, has acquired exclusive rights to two patented anticancer drugs, poised to ...

Coeptis Therapeutics Holdings, Inc. (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today ...

Baton, the leading marketplace for small and medium-sized business acquisitions, today announced its Series A raise of $10 million, led by Obvious Ventures with participation from Burst Capital, FJ ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

Cedric’s IBD journey began during his first year of college, when he experienced severe gastrointestinal symptoms leading to ...

“At AEON Clinic, we bridge the gap between science and health. Genomic insights allow us to address health risks at their ...